When the analysis was restricted to @ high-risk patients with an initial WBC count @ @ ( @ ) / L , the intergroup difference was statistically significant , with @-year RFS rates of @ % for the ATRA arm and @ % for the tamibarotene arm ( HR , @ ; @ % CI , @ to @ ) .